Feb 6 (Reuters) - PROMORE PHARMA AB PROMO.ST :
* OCTOBER TO DECEMBER NET SALES AMOUNTED TO MSEK 0.6 (0)
* OCT-DEC OPERATING LOSS FOR PERIOD WAS 10.6 (LOSS 3.6) MSEK
* "FOR 2018 OUR MAIN OPERATIONAL GOALS ARE TO CONTINUE PUSHING OUR MAIN PROJECTS FORWARD BY
START
RECRUITMENT IN CLINICAL TRIALS OF PXL01 AND LL-37"
* OCT-DEC NET LOSS WAS 11.0 (LOSS 2.4) MSEK, CORRESPONDING TO A LOSS PER SHARE OF SEK 0.54
(LOSS
0.18)
Source text for Eikon: ID:nWkr3dlJ42
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))